ArticleRheumatology advances in practice2022

Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis.

Masafumi Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.